CYP2A6 activity determined by caffeine phenotyping: Association with colorectal cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 4, 2002, Pages 377-383

  Nowell, Susan ^a,b   Sweeney, Carol ^b,d   Hammons, George ^d   Kadlubar, Fred F ^d   Lang, Nicholas P ^b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Department of Surgical Oncology ^*  (United States)

^c Central Arkansas Veterans Health Care System   (United States)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,7 DIMETHYL URIC ACID; CAFFEINE; CYTOCHROME P450 2A6; PARAXANTHINE; UNCLASSIFIED DRUG; URIC ACID DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; URINE LEVEL;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL MARKERS; CAFFEINE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; PHENOTYPE; RISK FACTORS; THEOPHYLLINE; URIC ACID;

EID: 0036120367     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Polymorphic N-acetylation of a caffeine metabolite
2. Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethytase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
3. Determination of CYPIA2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
4. Effect of age and smoking on in vivo CYPIA2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: Determination by caffeine metabolism
5. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYPIA2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping
6. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography
7. Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine
8. Relationship between the severity of alcoholic liver cirrhosis and the metabolism of caffeine in 226 patients
9. Caffeine metabolism differences in acute hepatitis of viral and drug origin
10. Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis
11. Caffeine urinary metabolite ratios as markers of enzyme activity: A theoretical assessment
12. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
13. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1
14. Human cytochrome P450IIA3: Cdna sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1
15. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: Correlation of 3-methyleneindolenine formation and protein-binding
16. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes
17. High variability of nitrosamine metabolism aong individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans
18. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand
19. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B I bioactivation in human liver with cirrhosis and hepatitis
20. CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis
21. CYP2A6 gene deletion reduces susceptibility to lung cancer
22. Nicotine metabolism defect reduces smoking
23. Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking
24. Genetic variation of CYP2A6, smoking, and risk of cancer
25. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: Implications for interindividual differences in nicotine metabolism
26. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method
27. Comparative metabolism of benzo[a]pyrene and drugs in human liver
28. Individual expression of carcinogen-metabolizing enzymes: Cytochrome P4502A
29. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons
30. Risk of colorectal and other gastrointestinal cancers after exposure to nitrate, nitrite and n-nitroso compounds: A follow-up study
31. Meat consumption and colorectal cancer: A review of epidemiologic evidence
32. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
33. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA 1 on colorectal cancer risk
34. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies
35. Colorectal cancer: Molecules and populations
36. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II
37. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
38. Interindividual variability of coumarin 7-hydroxylation in a Turkish population
39. Determination of drug-metabolizing enzyme activity in vivo: Pharmacokinetic and statistical issues